Asset Management Law360 provides breaking legal news and analysis on the asset management industry. Coverage includes litigation, policy developments, and corporate deals involving investment firms, mutual funds, hedge funds, bond funds, pension funds, and real estate investment trusts.
Sign up for a 7-day FREE trial today!
Latest News in Asset Management
-
July 27, 2026
A Delaware-based registered investment adviser has agreed to pay a $400,000 fine to the U.S. Securities and Exchange Commission to resolve claims that, among other things, it caused an affiliated trust to engage in prohibited transactions and separately caused one of its exchange-traded funds to exceed leverage thresholds for derivatives trading.
-
July 27, 2026
Defense and aerospace company ATI won escape from a proposed class action alleging it put retirees' benefits at risk by transferring approximately $1.5 billion of pension obligations to a private equity-backed insurance company, convincing a Pennsylvania federal court Monday that ex-workers hadn't sufficiently demonstrated standing to sue.
-
July 27, 2026
The Delaware Chancery Court has dismissed a stockholder challenge to Envestnet Inc.'s $4.5 billion take-private sale to Bain Capital affiliates, ruling that investors approved the deal through a fully informed vote and that the complaint failed to support claims that the company's independent directors or financial adviser Morgan Stanley acted improperly.
-
July 27, 2026
The managing partner of a New Hampshire-based private equity firm has pled guilty in New York federal court to multiple counts of fraud and money laundering in connection with a scheme that solicited over $50 million in investments for purported health and wellness companies.
-
July 27, 2026
A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant Avilar Therapeutics, misappropriated a Yale-developed trade secret for designing protein-degrading drug molecules.
See more Asset Management news